DUBLIN, Feb. 7, 2018 /PRNewswire/ — Theravance Biopharma Ireland Limited, a subsidiary of Theravance Biopharma, Inc. (NASDAQ: TBPH) (“Theravance Biopharma”) today announced that it has entered into a global co-development and commercialization agreement with Janssen Biotech, Inc., one of…